Skip to main content
. 2020 May 25;146(10):2669–2680. doi: 10.1007/s00432-020-03254-2

Fig. 3.

Fig. 3

Overall survival (OS) and Progression-free survival (PFS) curves with risk tables for patients with intermediate-stage recurrent HCC after hepatectomy who underwent TACE or TACE combined with ablation after propensity score matching. a OS curves after propensity score matching, b DFS curves after propensity score matching. TACE transcatheter arterial chemoembolization, CI confidence interval